GP combination therapy for treatment of 50 patients with advanced non-small cell lung cancer / 第三军医大学学报
Journal of Third Military Medical University
; (24)2003.
Article
in Zh
| WPRIM
| ID: wpr-678536
Responsible library:
WPRO
ABSTRACT
0 05). The median duration of survival was 8 5 months, and 1 year survival rate was 32 2%. Toxicity was chiefly hematologic in the form of neutropenia. The major non hematologic toxicity was nausea or vomiting. Conclusion The GP combination chemotherapy is an active regimen for the advanced NSCLC with tolerable toxicity.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Third Military Medical University
Year:
2003
Type:
Article